Jerry Chien-Chieh Huang1,2,3, Matthew Schleisman1, Dongseok Choi4, Claire Mitchell1, Lindsey Watson1, Mark Asquith5, James T Rosenbaum6,7. 1. Department of Ophthalmology, Oregon Health & Science University (OHSU), Portland, Oregon, USA. 2. Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan. 3. Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan. 4. OHSU-PSU School of Public Health, Oregon Health & Science University and Graduate School of Dentistry, Kyung Hee University, Seoul, Korea. 5. Department of Medicine, OHSU, Portland, Oregon, USA. 6. Departments of Ophthalmology, Medicine, and Cell Biology, OHSU, Portland, Oregon, USA. 7. Department of Ophthalmology, Legacy Devers Eye Institute, Portland, Oregon, USA.
Abstract
Purpose:Anterior uveitis is the most common anatomic subset of uveitis. We developed a novel multi-parametric flow cytometry panel to identify immune dysregulation signatures in HLA B27-associated acute anterior uveitis (AAU) and axial spondyloarthritis (AxSpA). Methods: We used fluorescence activated cell sorting to characterize T cell cytokine expression in stimulated T cell subsets from patients with AAU (n = 4) compared to healthy controls (n = 14) or subjects with AxSpA (n = 6). Results: Positive findings among subjects with AAU included a statistically significant increase in stimulated granulocyte-macrophage colony stimulating factor (GM-CSF), IL-17, and IL-22 synthesized by CD8 cells, a trend for stimulated ILC (innate lymphoid cells)-3 cells to synthesize more IL-22 (p = .07), and stimulated MAIT (mucosa associated innate lymphoid cells)-like cells that express the T cell receptor V alpha 7.2 to express IL-17A, IL-17F, and IL-22 in a greater percentage of cells relative to controls. IL-17F, GM- CSF, and IL-22 represent potentially novel targets in AAU. Conclusion: Our report is arguably the first to implicate IL-17F or ILC-3 and MAIT cells in the pathogenesis of AAU.Abbreviations AAU: acute anterior uveitis; AxSpA: axial spondyloarthritis; BASDAI: Bath ankylosing spondylitis disease activity index; CCR: chemokine receptor; DMSO: dimethylsulfoxide; EULAR:European League Against Rheumatism; FACS: fluorescence activated cell sorter; FBS: fetal bovine serum; FSC: orward light scatter; GM-CSF: granulocyte-macrophage colony stimulating factor; HC: healthy control; ILC: innate lymphoid cell; KIR: killer immunoglobulin receptor; MAIT: mucosal associated immune T cell; ND: not detected; NK: natural killer cell; OHSU-Oregon Health & Science University; PBMC: peripheral blood mononuclear cell; SSC: side light scatter; TCR: T cell receptor.
Purpose:Anterior uveitis is the most common anatomic subset of uveitis. We developed a novel multi-parametric flow cytometry panel to identify immune dysregulation signatures in HLA B27-associated acute anterior uveitis (AAU) and axial spondyloarthritis (AxSpA). Methods: We used fluorescence activated cell sorting to characterize T cell cytokine expression in stimulated T cell subsets from patients with AAU (n = 4) compared to healthy controls (n = 14) or subjects with AxSpA (n = 6). Results: Positive findings among subjects with AAU included a statistically significant increase in stimulated granulocyte-macrophage colony stimulating factor (GM-CSF), IL-17, and IL-22 synthesized by CD8 cells, a trend for stimulated ILC (innate lymphoid cells)-3 cells to synthesize more IL-22 (p = .07), and stimulated MAIT (mucosa associated innate lymphoid cells)-like cells that express the T cell receptor V alpha 7.2 to express IL-17A, IL-17F, and IL-22 in a greater percentage of cells relative to controls. IL-17F, GM- CSF, and IL-22 represent potentially novel targets in AAU. Conclusion: Our report is arguably the first to implicate IL-17F or ILC-3 and MAIT cells in the pathogenesis of AAU.Abbreviations AAU: acute anterior uveitis; AxSpA: axial spondyloarthritis; BASDAI: Bath ankylosing spondylitis disease activity index; CCR: chemokine receptor; DMSO: dimethylsulfoxide; EULAR:European League Against Rheumatism; FACS: fluorescence activated cell sorter; FBS: fetal bovine serum; FSC: orward light scatter; GM-CSF: granulocyte-macrophage colony stimulating factor; HC: healthy control; ILC: innate lymphoid cell; KIR: killer immunoglobulin receptor; MAIT: mucosal associated immune T cell; ND: not detected; NK: natural killer cell; OHSU-Oregon Health & Science University; PBMC: peripheral blood mononuclear cell; SSC: side light scatter; TCR: T cell receptor.
Authors: Erik Letko; Steven Yeh; C Stephen Foster; Uwe Pleyer; Mitchell Brigell; Cynthia L Grosskreutz Journal: Ophthalmology Date: 2015-01-29 Impact factor: 12.079
Authors: Fleurieke H Verhagen; Sanne Hiddingh; Rianne Rijken; Aridaman Pandit; Emmerik Leijten; Michel Olde Nordkamp; Ninette H Ten Dam-van Loon; Stefan Nierkens; Saskia M Imhof; Joke H de Boer; Timothy R D J Radstake; Jonas J W Kuiper Journal: Front Immunol Date: 2018-10-31 Impact factor: 7.561
Authors: Peter C Taylor; Didier Saurigny; Jiri Vencovsky; Tsutomu Takeuchi; Tadashi Nakamura; Galina Matsievskaia; Barbara Hunt; Thomas Wagner; Bernard Souberbielle Journal: Arthritis Res Ther Date: 2019-04-18 Impact factor: 5.156
Authors: Dominique Baeten; Xenofon Baraliakos; Jürgen Braun; Joachim Sieper; Paul Emery; Désirée van der Heijde; Iain McInnes; Jacob M van Laar; Robert Landewé; Paul Wordsworth; Jürgen Wollenhaupt; Herbert Kellner; Jacqueline Paramarta; Jiawei Wei; Arndt Brachat; Stephan Bek; Didier Laurent; Yali Li; Ying A Wang; Arthur P Bertolino; Sandro Gsteiger; Andrew M Wright; Wolfgang Hueber Journal: Lancet Date: 2013-09-13 Impact factor: 79.321
Authors: Ruth J Napier; Ellen J Lee; Michael P Davey; Emily E Vance; João M Furtado; Paige E Snow; Kimberly A Samson; Sydney J Lashley; Brieanna R Brown; Reiko Horai; Mary J Mattapallil; Biying Xu; Michelle C Callegan; Luke S Uebelhoer; Christina L Lancioni; Richard K Vehe; Bryce A Binstadt; Justine R Smith; Rachel R Caspi; Holly L Rosenzweig Journal: Nat Commun Date: 2020-10-26 Impact factor: 14.919